Navigation Links
Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch
Date:10/6/2010

CHAPEL HILL, N.C., Oct. 6 /PRNewswire/ -- Pharmaceutical and biotech companies reach much greater and sustained product success when they ensure strong partnerships between R&D and marketing, balancing therapeutic innovation with commercial focus in all stages of product development. It requires companies to break down the walls that have traditionally separated R&D from marketing and instead leverage the strengths of both talented medical researchers and skillful marketers.

Best Practices LLC's benchmarking report, Best Practices in Global Pharmaceutical Launches, outlines just what commercially focused R&D looks like. For example, marketing organizations have now assumed an active role in conducting early and continuous market research and interacting with thought leaders to identity unmet medical needs, assess market opportunities, drive product profile development and positioning, and create customer demand and brand loyalty.

For more information, sample practices and graphics from this report, download a complimentary excerpt at http://www3.best-in-class.com/rr1025.htm.  

Analysts harvested survey data and qualitative best practices from informed executives at elite pharmaceutical companies, including Merck, Pfizer, Johnson & Johnson, Bristol-Myers Squibb and Novartis.  The report includes over 180 metrics, 100 best practices and 20 company narratives on critical pre and post launch topics, including:
 

  • Marketing Launch Strategy and Structure
  • Marketing Investment and Staffing
  • Cross-Functional Launch Team Composition and Management
  • Thought Leader Development
  • Sales Force Support and Compensation Management
  • Market Research
  • Marketing Activities
  • Life Cycle Management
     

A small sample of the compelling best practices shared include:
 

  • Top-performing benchmark partners invested significant financial and human resources to ensure the initial and on-going success of important new products. For a blockbuster drug with potential annual sales of at least $500 million ~ $1 billion within 3-4 years following launch, these companies spent between $100 million and $500 million in marketing dollars.
  • Benchmark partners stressed the importance of managing thought leader development as an integrated, multi-phased process. Companies seek to tailor their efforts, activities and relationship investments to match the value of each thought leader segment and to reflect the roles of each segment at different points in time.

Product and marketing executives seeking to improve their own drug launch process will find this detailed report invaluable for learning how the best in the world do it.  By implementing the basic drug launch formulas of best-in-class organizations, companies can fine-tune their products' positioning with added assurances of success.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
2. Graymark Healthcare Agrees to Sell Pharmacy Division to Walgreens Creating Pure Play Sleep Apnea Company
3. Empire BlueCross BlueShield Expands Lab Networks -- Creating Broader Choice, Robust Competition and Lower Costs for Consumers
4. Learn How Merck is Creating a Unified Culture and Company Brand During NewsGator Webinar Entitled: From MyMerck to OneMerck - Enterprise 2.0
5. Creating Healthcare Reform from the Inside Out Through Supply Chain Best Practices that Improve Financial and Clinical Performance is Focus of 2010 GHX Supply Chain Summit
6. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
7. CMS Admits New Surety Bond and Accreditation Requirement for Home Medical Equipment Suppliers Creating Patient Access Issues
8. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
9. Codexis Expands Pharmaceutical Manufacturing Partnerships
10. PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
11. PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... , May 24, 2016 Open ... in Clinical Neurophysiology  Elsevier , a ... and services, today announced the launch of ... access journal that focuses on clinical practice issues in ... reports, clinical series, normal values and didactic reviews. It ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... One Florida-based plastic surgeon’s ... according to an article published May 13th on Vanity Fair. In fact, ... having snippets of their procedures broadcast to more than 800,000 Snapchat fans. Commenting on ...
(Date:5/25/2016)... ... 25, 2016 , ... Indiana Fiber Network, LLC (IFN), the ... IFN as a fiber transport provider. IFN provided Lake City Bank with network ... , “IFN provides fiber transport to Lake City Bank, which includes ...
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot ... by CIOReview. , In a deliberate session with the honorary industrial experts, a list ... concluded with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample ...
(Date:5/25/2016)... ... May 25, 2016 , ... DKT International, one of ... world, is pleased to release their 2015 global impact data. In 2015, DKT ... 14,000 maternal deaths and 3.8 million unsafe abortions across 21 countries worldwide. ...
(Date:5/25/2016)... ... 2016 , ... Casa Velas, an adults-only boutique hotel in Puerto Vallarta, Mexico, ... new wellness suites . The two 1,350 sq. ft. suites which debuted in ... and insuite amenities, from a custom soap selection and in-suite exercise kit to a ...
Breaking Medicine News(10 mins):